Condensed Statement of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2020	$ 328,609	$ 43	$ 822,624	$ 1	$ (494,059)
Beginning Balance (shares) at Dec. 31, 2020		42,722
Issuance of common stock through employee stock purchase plan	1,838		1,838
Issuance of common stock through employee stock purchase plan (shares)		80
Stock option exercises	380		380
Stock option exercises (shares)		86
Stock-based compensation expense	5,852		5,852
Unrealized loss on available-for-sale securities	(9)			(9)
Net loss	(30,025)				(30,025)
Ending Balance at Mar. 31, 2021	306,645	$ 43	830,694	(8)	(524,084)
Ending Balance (shares) at Mar. 31, 2021		42,888
Beginning Balance at Dec. 31, 2020	328,609	$ 43	822,624	1	(494,059)
Beginning Balance (shares) at Dec. 31, 2020		42,722
Unrealized loss on available-for-sale securities	(29)
Net loss	(60,233)
Ending Balance at Jun. 30, 2021	431,162	$ 46	985,436	(28)	(554,292)
Ending Balance (shares) at Jun. 30, 2021		46,225
Beginning Balance at Mar. 31, 2021	306,645	$ 43	830,694	(8)	(524,084)
Beginning Balance (shares) at Mar. 31, 2021		42,888
Issuance of common stock upon initial public offering, net of issuance costs	149,085	$ 3	149,082
Issuance of common stock upon initial public offering, net of issuance costs (shares)		2,946
Issuance of common stock for settlement of RSUs (shares)		1
Stock option exercises	1,723		1,723
Stock option exercises (shares)		390
Stock-based compensation expense	3,937		3,937
Unrealized loss on available-for-sale securities	(20)			(20)
Net loss	(30,208)				(30,208)
Ending Balance at Jun. 30, 2021	431,162	$ 46	985,436	(28)	(554,292)
Ending Balance (shares) at Jun. 30, 2021		46,225
Beginning Balance at Dec. 31, 2021	374,081	$ 47	1,000,212	(184)	(625,994)
Beginning Balance (shares) at Dec. 31, 2021		47,241
Issuance of common stock through employee stock purchase plan	2,063		2,063
Issuance of common stock through employee stock purchase plan (shares)		55
Issuance of common stock for settlement of RSUs (shares)		88
Stock option exercises	1,660	$ 1	1,659
Stock option exercises (shares)		328
Stock-based compensation expense	5,006		5,006
Unrealized loss on available-for-sale securities	(465)			(465)
Net loss	(36,892)				(36,892)
Ending Balance at Mar. 31, 2022	345,453	$ 48	1,008,940	(649)	(662,886)
Ending Balance (shares) at Mar. 31, 2022		47,712
Beginning Balance at Dec. 31, 2021	374,081	$ 47	1,000,212	(184)	(625,994)
Beginning Balance (shares) at Dec. 31, 2021		47,241
Unrealized loss on available-for-sale securities	(771)
Net loss	(80,731)
Ending Balance at Jun. 30, 2022	309,764	$ 48	1,017,396	(955)	(706,725)
Ending Balance (shares) at Jun. 30, 2022		47,997
Beginning Balance at Mar. 31, 2022	345,453	$ 48	1,008,940	(649)	(662,886)
Beginning Balance (shares) at Mar. 31, 2022		47,712
Issuance of common stock for settlement of RSUs	1,042		1,042
Issuance of common stock for settlement of RSUs (shares)		52
Stock option exercises (shares)		233
Stock-based compensation expense	7,414		7,414
Unrealized loss on available-for-sale securities	(306)			(306)
Net loss	(43,839)				(43,839)
Ending Balance at Jun. 30, 2022	$ 309,764	$ 48	$ 1,017,396	$ (955)	$ (706,725)
Ending Balance (shares) at Jun. 30, 2022		47,997